Related by context. All words. (Click for frequent words.) 59 Files IND 59 DNA intercalator 59 Kinase Inhibitor 59 targeted radiotherapeutic 58 ARC# [002] 58 Alfacell proprietary ribonuclease 58 histone deacetylase HDAC inhibitor 57 orally administered inhibitor 57 Cathepsin S 57 therapeutic monoclonal antibody 57 non nucleoside inhibitor 57 ALN TTR 57 selective antagonist 56 humanized monoclonal 56 triciribine phosphate monohydrate 56 novel histone deacetylase 56 Bruton tyrosine kinase Btk 56 JAK2 inhibitor 56 maturation inhibitor 56 PNP inhibitor 56 THR beta agonist 56 cyclin dependent kinase inhibitor 55 solithromycin 55 TRX1 55 initiated Phase Ib 55 Janus kinase 55 histone deacetylase HDAC 55 C#T [002] 55 2 methoxyestradiol 55 RNAi Therapeutic 55 Cloretazine ® 55 Monoclonal antibody 55 tumor vascular disrupting 55 highly selective inhibitor 55 EP# [003] 55 Novel Oral 55 Janus Kinase 55 cholesteryl ester transfer 55 HTS assay 55 glycopeptide 55 oral proteasome inhibitor 55 NEUGENE 55 mediated inhibition 55 triple VEGF receptor 55 proteasome inhibitor 55 CCR5 antagonist 55 Issued Patent 55 Cytochrome P# 55 NS5b 55 selective estrogen receptor modulator 55 sunitinib Sutent ® 54 Panzem R 54 Iluvien ® 54 Mycophenolate Mofetil 54 Therapeutic Vaccine 54 refractory chronic lymphocytic 54 Anavex #-# 54 DB# [003] 54 targeted antifolate 54 IMA# 54 selective kinase inhibitor 54 XYOTAX TM 54 Vitro Activity 54 targeting CD# 54 rxRNA 54 ALN HPN 54 glycoprotein GP IIb IIIa 54 UPLYSO 54 # COA R3 54 KB# [002] 54 generation purine nucleoside 54 intranasal formulation 54 ARX# [002] 54 dasatinib Sprycel ® 54 muscarinic receptor agonist 54 HuMax 54 selective adenosine 54 Onconase 54 PDX pralatrexate 54 Files Investigational 54 selective serotonin 2C receptor 54 GSK '# 54 small molecule chemotherapeutic 54 include Phenoptin TM 54 neuronal nicotinic receptor NNR 54 Forodesine 54 Nucleic Acids Res 54 iSONEP ™ 54 ABL inhibitor 54 Initiates Phase 2b 54 Sphingomab TM 54 brivanib 54 Perflubutane Polymer Microspheres 54 aurora kinase 54 Micromet BiTE 54 Drug Candidate 54 ASCO Abstract 54 selective orally bioavailable 54 polymerase inhibitor 54 Liposomal 53 Factor VIIa 53 cathepsin K inhibitor 53 First Patient Dosed 53 MAGE A3 ASCI 53 GW# [003] 53 histamine dihydrochloride 53 Polymer Microspheres 53 potently inhibit 53 Cloretazine 53 Initiates Clinical Trial 53 Successfully Completes Phase 53 PI3K/Akt pathway inhibitor 53 Bafetinib 53 accumulate preferentially 53 XWAY ARX# 53 Epirubicin 53 antisense inhibitor 53 DNA demethylating agent 53 Alferon N 53 thalidomide Thalomid 53 Aztreonam 53 Meets Primary Endpoint 53 Xeomin ® 53 Patents Upheld 53 Qutenza TM 53 TLK# 53 multi kinase inhibitor 53 epoetin zeta 53 tubulin inhibitor 53 NS5B polymerase 53 inhaled AAT 53 H.# Encoder 53 reverse transcriptase inhibitors 53 EndoTAG TM -1 53 Kamada AAT 53 Grb 2 53 investigational humanized monoclonal antibody 53 Neuroprotection 53 selective agonist 53 Presents Preclinical Data 53 signal transduction inhibitor 53 DermaVir Patch 53 Sphingomab 53 SynCon ™ DNA 53 Aliskiren 53 candidate deforolimus 53 imatinib Gleevec ® 53 Initiate Clinical Trial 53 Angiolix R 53 AMCC QT# 53 antiangiogenic agent 53 demethylating agent 53 RhuDex TM 53 Dalbavancin 53 novel orally administered 53 Panzem R NCD 53 palifosfamide Zymafos TM 53 MET VEGFR2 53 potent cytotoxic 53 histone deacetylase inhibitor 53 Aflibercept 53 recombinant FVIII 53 Deadlinepix 53 SGLT 2 53 Levocetirizine 53 SUTENT ® 53 seliciclib CYC# 53 overactive bladder AA# 53 Initiates Phase II 53 apoptosis inducers 53 ara C 53 immunotherapeutic agent 53 WP# [002] 53 mGluR2 NAM 53 Pharmacokinetics PK 53 Nektar proprietary 53 Tamoxifen Citrate 53 molecular imaging radiopharmaceutical 53 ALTROPANE R 53 Aurora Kinase 53 Granted Orphan Drug 53 Anticalin R 53 protein tyrosine phosphatase 1B 53 JAK2 Inhibitor 52 PCI Express PHY 52 Completes Patient Enrollment 52 Monoclonal Antibody 52 5 HT2A serotonin 52 Antibody Drug Conjugate 52 ENMD # 52 NPC 1C 52 PEGylated interferon 52 Silodosin 52 HCV polymerase 52 fludarabine phosphate 52 selectively inhibits 52 CELLECTRA R 52 VivaGel ™ 52 Submits NDA 52 ACC2 52 SMIP 52 Factor Receptor 52 metaglidasen 52 Demonstrates Significant 52 TMC# [002] 52 Pegylated Liposomal Doxorubicin 52 cMet 52 #C# [010] 52 HDAC Inhibitor 52 novel oral anticoagulant 52 REP# 52 Cyclosert 52 treat chronic sinusitis 52 PN# [001] 52 TransVax tm 52 Bipolar Transistor 52 ALN PCS 52 VentiRx Pharmaceuticals 52 CDK inhibitor 52 delipidation 52 humanized anti 52 proprietary polysaccharide 52 Nasulin TM 52 topical gel formulation 52 TG# [003] 52 c KIT 52 Panzem NCD 52 SynCon TM DNA 52 Interferon alpha 52 MSM# TM chipset 52 ASONEP TM 52 EZN 52 ATL/TV# 52 chemokine receptor 52 Embedded Processors 52 oral anti arrhythmic 52 Purine 52 Safinamide 52 OvaRex R 52 CYP #C# 52 arginine vasopressin AVP 52 ARX# [001] 52 RTP #i 52 Therapeutic Competitors Report 52 DP VPA 52 vivo fluorescence imaging 52 R Bambuterol 52 ACAPODENE TM 52 Adenoscan R 52 PI3 52 RhuDex ® 52 non nucleoside HCV 52 Voreloxin 52 non porcine pancreatic 52 Archexin 52 Initiates Clinical 52 Universal Flu Vaccine 52 Chipcon CC# 52 Anticalin ® 52 Tofacitinib 52 Receives Orphan Drug Designation 52 Spiegelmer ® 52 irreversible inhibitor 52 Polymorphism 52 hyaluronidase enzyme 52 Suppl. 52 #HT# 52 XmAb TM 52 mertansine 52 synthetic siRNA 52 selective phosphodiesterase 52 GV# [001] 52 radiation sensitizer 52 BLyS specific 52 monoclonal antibody mAb 52 vapreotide acetate 52 Antigenics QS 52 PEG Interferon 52 CYP#A# CYP#D# 52 Lenalidomide 52 Tarvacin TM 52 Tumor Angiogenesis 52 Chemokine Receptor 52 poly ADP ribose polymerase 52 entitled Compositions 52 highly selective endothelin 52 chimeric monoclonal antibody 52 M Enoxaparin 52 personalized dendritic 52 essential thrombocythemia ET 52 cortisol synthesis 52 Phase #b/#a clinical 52 liposomal formulation 52 Vaxfectin R formulated 52 ABLYNX 52 selective immunoproteasome inhibitor 52 Zonisamide 52 Solzira ™ 52 ATL# [002] 52 Vidaza R 52 replicon 52 VNP#M 52 Differential Quadrature Phase 52 Glatiramer Acetate 52 AFREZZA TM 52 Fodosine 52 Initiates Enrollment 52 MVA HPV IL2 52 SG# [003] 52 Cytotoxic 52 Zemiva ™ 52 candidates bavituximab 52 Oral NKTR 52 Xyfid TM 52 immunoconjugate 52 JVRS 52 novel emulsion formulation 52 TRIOLEX ™ 52 topoisomerase II inhibitor 52 hydroxamic acid 52 Auxilium transmucosal film 52 Zoraxel TM 52 murine monoclonal antibody 52 Trofex 52 Phase Ib Clinical Trial 52 factor VIIa 52 Antitumor 52 Delafloxacin 52 TELINTRA R 52 platform HDL Mimetic 52 TLR agonists 52 SO DIMM 52 MT# MEDI 52 Ampligen ® 52 Multimeric 52 Cyclosert TM 52 Abacavir Sulfate 52 EVIZON ™ 52 Hsp# Inhibitor 52 Begins Shipment 52 Accelerated Intelligent 52 receptor tyrosine kinase inhibitor 52 synDNA TM 52 M#V 51 Hepatitis C Virus HCV 51 oral prodrug 51 Interferon alfa 51 platinum chemotherapeutic 51 tSMS 51 IKK epsilon 51 potency selectivity 51 PORxin TM 51 Xenazine ® 51 Carbidopa Levodopa 51 isoform selective 51 Antigen Specific 51 TLR9 agonist 51 acyclovir Lauriad R 51 Valortim TM 51 Nicotinic 51 Uses Thereof 51 Solazed 51 MGd 51 KRN# 51 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 51 Announces Tentative Approval 51 selective adhesion molecule 51 LymphoStat B TM 51 XWAY 51 taxane derivative 51 Transdrug R 51 non peptidic protease 51 Phenotyping 51 ASONEP ™ 51 Multiferon R multi 51 nanopharmaceutical 51 Phase 2a Clinical Trial 51 anticancer compound 51 Ribosomal 51 immunomodulating 51 tyrosine kinase receptor 51 NET# [002] 51 B lymphocyte stimulator 51 CellularRAM 51 Calando proprietary 51 Varespladib 51 Shigamabs ® 51 DNA methyltransferase inhibitors 51 Iluvien TM 51 Leukotriene 51 Abstract Number 51 Fenretinide 51 Glycosylation 51 anti angiogenic agent 51 Potelligent Technology 51 CYT# vascular disrupting 51 Home NodeB 51 Submits IND 51 patented Bioral 51 BAL# [002] 51 Diazyme 51 DiLA2 51 candidate REP# 51 inverse agonist 51 Pyridorin 51 PANVAC VF 51 mitogen activated ERK kinase 51 HCV polymerase inhibitor 51 inhibits protein synthesis 51 polysaccharide polymer 51 pan histone deacetylase 51 novel VDA molecule 51 TRO# 51 Annexin A5 51 SNP Genotyping 51 Teva Provides Update 51 small molecule Hedgehog 51 CYT# potent vascular disrupting 51 ErbB1 51 Bazedoxifene 51 Immunotherapeutic 51 Factor VIIa inhibitor 51 Glucophage R 51 ActA 51 AAG geldanamycin analog 51 LentiVector 51 selective modulator 51 negative allosteric modulator 51 PEG IFN 51 OMP #M# 51 Enkephalin 51 Medoxomil 51 IAP inhibitor 51 Horizant ™ 51 NeuroSTAT ® 51 HDMI Transmitter 51 Anticalins 51 Intermezzo ® zolpidem tartrate 51 POTELLIGENT ® 51 Ad5FGF 4 51 IGF 1R inhibitor 51 Adenoviral 51 huN# DM1 51 Afatinib 51 Inhaled AAT 51 IND Application 51 topically administered 51 MorphoSys proprietary 51 5 HT2C 51 Initiated Phase 51 R roscovitine 51 Nexxis 51 selective A2A adenosine receptor 51 pretreatment serum 51 Tesetaxel 51 HCl Injection 51 Orally administered 51 drug conjugates 51 torezolid 51 Treated Patients 51 Valtropin 51 Guanilib 51 JZP 51 generation antisense inhibitor 51 Generx ™ 51 Aplidin R 51 OXIGON 51 histone deacetylase 51 REMINYL ® 51 Ultratrace 51 SPL# Gel vaginal microbicide 51 Elagolix 51 peripherally restricted 51 Panzem ® 51 XL# anticancer compounds 51 5 HT3 antagonist 51 Integrase 51 Nasulin ™ 51 Novosom 51 omacetaxine mepesuccinate 51 Anidulafungin 51 Omacetaxine 51 2 inhibitor CYT# 51 tkRNAi 51 HyperAcute 51 Cloretazine R 51 broad spectrum cephalosporin 51 covalently linked 51 siRNA therapeutic 51 Copegus ribavirin 51 Nanobody ® 51 Interferon gamma 51 Pharmacokinetic Study 51 Anthrax Toxin 51 5 HT2C serotonin 51 Bruton tyrosine kinase 51 Wins Patent Infringement 51 vascular disrupting agents 51 Crucell PER.C6 51 Kahalalide F 51 iSONEP TM 51 non nucleoside 51 beta lactams 51 BRILINTA 51 Prodrug 51 Baseband Processor 51 XWAY TM 51 MSM# TM MSM# TM 51 Solazed ™ 51 nucleoside reverse transcriptase inhibitor 51 IMPDH inhibitor 51 vascular disrupting agent 51 SinuNase ™ 51 fosbretabulin 51 CA9 SCAN 51 Upregulation 51 RELOVAIR ™ 51 PF # [002] 51 oral antiviral 51 alpha folate receptor 51 siRNAs targeting 51 Nexavar ® 51 Genisphere 51 Phase Ib study 51 potently inhibits 51 triggers apoptosis programmed 51 mda 7 51 Phase IIb Trial 51 HuCAL GOLD R 51 picoArray 51 novel immunotherapeutic 51 folate analogue metabolic 51 Pafuramidine 51 thrombin receptor 51 recombinant fusion 51 protein tyrosine phosphatase 51 Gets FDA Clearance 51 MIPS PowerPC 51 OrbusNeich patented endothelial progenitor 51 Reports Preclinical Data 51 CCR5 inhibitor 51 HuCAL antibodies 51 HCV protease inhibitor 51 gemcitabine Gemzar ® 51 AKT inhibitor 51 Launches Generic Version 51 protein tyrosine 51 Small Molecule 51 Vascular Wrap TM 51 Study Evaluating 51 Aldara ® 51 OHR/AVR# 51 Mg Usa 51 Ixabepilone 51 immunomodulatory properties 51 RTL# 51 Civacir 51 Gemzar ® 51 Parathyroid Hormone 51 Kinase Inhibitors 51 Daclizumab 51 Nephrol 51 Camptosar ® 51 PDE4 inhibitor 51 Lanthanum carbonate 51 Procardia XL 51 Polymerase Inhibitor 50 Secretase 50 peripherally acting 50 KL4 Surfactant 50 Alkaline Phosphatase 50 vinorelbine tartrate 50 Ceftaroline 50 HIV integrase inhibitor 50 Moxifloxacin 50 HDL Mimetic Peptide 50 sucrose enhancer 50 monoclonal antibody MAb 50 cyclin dependent kinase CDK 50 BLP# Liposome Vaccine 50 Preclinical studies indicate 50 HepDirect prodrug 50 Protease Inhibitor 50 SYN# 50 monoclonal antibody conjugated 50 reversible inhibitor 50 Prolongs Survival 50 VitiGam 50 virus HCV protease inhibitor 50 Lanthanum Carbonate 50 Sudhir Agrawal D.Phil 50 hypoxia selective 50 Chinese Hamster Ovary 50 Annamycin 50 Aroplatin 50 sitagliptin metformin 50 mTOR mammalian target 50 selective inhibitor 50 SDK v#.# 50 HCV polymerase inhibitors 50 5 HT2A inverse 50 Plasma Protein 50 Percutaneous Tibial Nerve Stimulation 50 Pertuzumab 50 Multimedia Processor 50 Kuvan TM sapropterin 50 Personalized Immunotherapy 50 Aptamer 50 anti CD3 monoclonal 50 aurora kinase inhibitor 50 epigenetic therapies 50 Pruvel TM 50 active cellular immunotherapy 50 Investigational Oral 50 HCQ 50 oral isotype selective HDAC 50 Januvia sitagliptin 50 Genetic Analyzer 50 ficlatuzumab 50 oral tyrosine kinase 50 Squalamine 50 TPI ASM8 50 Antiviral Therapy 50 LX# LX# 50 Patent Lawsuit 50 Announce Collaboration Agreement 50 potent antiproliferative 50 investigational antibiotic 50 plasmid DNA encoding 50 product candidate Lpathomab 50 Septin9 biomarker 50 Interphase iSPAN 50 Interferon Beta 50 NS5A inhibitor 50 Affymetrix GeneChip 50 Block Diagram 50 orally bioavailable 50 Celeron Dual Core 50 Recombinant Protein 50 agent bevasiranib 50 miconazole Lauriad ® 50 stable nucleic acid 50 TELCYTA R 50 TAT# 50 Asthma COPD 50 THine 50 small molecule tyrosine 50 agonistic human 50 KSP inhibitor 50 Cardiotoxicity 50 PT# Pro 50 XP# XP# 50 beta lactamase inhibitor 50 TLR antagonist 50 SynCon 50 Nasdaq ACHN 50 M2 subunit 50 Respiratory Virus 50 ALTERA 50 Integrase Inhibitor 50 NM# [003] 50 Respiratory Viral Panel 50 selectively inhibiting 50 Tyrosine Kinase Inhibitor 50 toenail onychomycosis 50 Assay Kit 50 selectively inhibited 50 Arcelis ™ 50 Hycamtin ® 50 Technosphere ® 50 Trofex ™ 50 Spiegelmer 50 induced mucositis 50 developing TB4 50 Submits Supplemental 50 Vidofludimus 50 @ Tweaktown 50 Atripla combines 50 Proteasome 50 reslizumab 50 LHRH antagonists 50 PGL# 50 Oxytrex TM 50 HCV NS3 protease 50 Hemodiafiltration 50 zinc cysteine 50 Piperacillin 50 CG# [003] 50 rusalatide acetate 50 lipid biosynthesis 50 PI3K/mTOR 50 HIV integrase inhibitors 50 Teriflunomide 50 bevacizumab Avastin R 50 personalized immunotherapy 50 SGLT 50 lexidronam injection 50 Indomethacin 50 Cloretazine VNP#M 50 CCX# B 50 novel synthetic peptide 50 Genotyping Test 50 Bosutinib 50 nitric oxide donating prostaglandin 50 adenosine A2A 50 NS5A 50 peptide conjugated 50 mTOR inhibitor 50 ISENTRESS raltegravir 50 treats acute lymphoblastic 50 XOMA 3AB 50 SensoLyte ® 50 florbetaben 50 XL# XL# 50 compound AEZS 50 sulfonylhydrazine class 50 include GALNS N 50 V#E 50 ChronVac C R 50 Protein Kinase C 50 5 Fluorouracil 50 M# rationally 50 Mindspeed Transcede 50 #mg/#mg 50 Ceflatonin R 50 AmpliChip 50 USB ExpressCard UE 50 tiapamil 50 PPARgamma 50 Phase IIa Clinical Trial 50 ceftazidime 50 Entry Inhibitor 50 romidepsin novel 50 OCT# [003] 50 Nanobody 50 therefore therapeutically equivalent 50 Mg Uk 50 oral picoplatin 50 Systemic Delivery 50 IgG1 monoclonal antibody 50 ARM#EJ S ™ 50 Phase 2b Study 50 acadesine 50 IMiDs R 50 androgen receptor antagonist 50 Investigational Drug 50 Monoclonal 50 HyACT 50 AzaSite ISV 50 volociximab 50 Pimavanserin 50 TRANSDUR Bupivacaine 50 ARRY # 50 Extends Capabilities 50 Xanafide 50 Resten MP 50 CupPrint R 50 Biomarker Study 50 ONX 50 Triapine 50 Accelerate Commercialization 50 matrix metalloproteases 50 Aganocide 50 Gamma secretase 50 HemosIL 50 Ofloxacin 50 pan HDAC inhibitor 50 CIP Fenofibrate 50 humanized monoclonal antibody 50 Investigational eFlow Nebulizer System 50 Bioral ® 50 Novel Inhibitor 50 EasyCyte 50 JAK Inhibitor 50 Human Leukocyte Antigen 50 methionine aminopeptidase 50 NASH Huntington 50 Kosan dependence 50 Spiegelmers 50 potent anticancer 50 binds selectively 50 vPort 50 Teysuno 50 Fixed Dose Combination 50 PAM4 50 GPON SoC 50 MKC# MKC# PP 50 Synerx Pharma 50 Media5 fone 50 MF# [002] 50 MEK inhibitor 50 Epidermal Growth Factor Receptor 50 PrevOnco 50 Aeolus Pharmaceuticals Announces 50 SPRYCEL ® 50 orally dosed 50 orally inhaled migraine 50 Orthop Surg 50 beta 1a 50 AurSCOPE 50 IMiD 50 Apoptone 50 ADP receptor antagonist 50 NS3 protease 50 gefitinib Iressa 50 Valganciclovir 50 evaluating tivozanib 50 TMS#DM# [002] 50 BIIB# 50 Alkeran 50 Late Breaker 50 NeoLipid R 50 nP# 50 Panther Trak 50 mGluR2 positive 50 proprietary HuCNS SC 50 A3 adenosine receptor 50 immunotoxin 50 BrachySil ™ 50 PEGylated Fab fragment 50 Patent Infringement Litigation 50 Emtriva Viread 50 Carfilzomib 50 MKC# MT 50 phospholipase C 50 Xcytrin R 50 Capillary Electrophoresis 50 GVAX ® 50 Vaccine Adjuvants 50 Settles Patent Litigation 50 ionotropic glutamate receptor antagonists 50 Fulvestrant 50 Polymerase 50 JAK inhibitor 50 HCV NS5B polymerase 50 thetreatment 50 Expedited Review 50 Novel Antibiotic 50 Fondaparinux 50 1mg 2mg 50 protein biochip 50 fusion inhibitor 50 NRTI resistance 50 Maximum Tolerated Dose MTD 50 AMD# [002] 50 Announces Licensing Agreement 50 EGFR HER2 50 Hemopurifier ® 50 Vascular Disrupting Agent 50 immunostimulatory 50 MGN# 50 SuperAntibody 50 #DE# 50 dihydrofolate reductase 50 Oritavancin 50 TransPharma 50 G#DT 50 HuCAL R 50 Serostim ® 50 novel L DOS# 50 investigational oral inhibitor 50 alpha 2b 50 Preclinical Data 50 VISICOL R 50 #:#-# [020] 50 urate oxidase 50 targeted tyrosine kinase 50 Modrenal R 50 BAL# [001] 50 etanercept Enbrel 50 Altair FourGee 50 WiMAX GSM EDGE 50 E# E# [002] 50 alemtuzumab Campath 50 SynCon TM 49 E# [005] 49 Azedra ™ 49 Vinorelbine 49 demonstrated antitumor activity 49 PDE# inhibitors 49 Melphalan 49 peginterferon alpha 49 REG2 49 Elvitegravir 49 #G DPSK 49 ropinirole Requip 49 Fludase 49 BEMA Granisetron 49 Btk inhibitor 49 Alzhemed TM 49 AEGR 49 Lyophilized 49 Diarrheal 49 Pemetrexed 49 Receptor Antagonist 49 esomeprazole magnesium 49 IND Investigational New 49 PARI Pharma GmbH 49 LPTN 49 bacterial biothreat agents 49 glucokinase activator 49 HSP# inhibitor 49 candidate ATHX 49 mouse xenograft models 49 topically applied SEPA 49 anti botulism antibody 49 selective inverse agonist 49 lymphoid malignancies 49 Plaque Psoriasis 49 cat dander allergy 49 Telatinib 49 PIN photodiodes 49 Anticalins ® 49 antiproliferative activity 49 iMB 49 radiolabeled 49 AT# [001] 49 ghrelin antagonist 49 Artikel Zum Thema 49 MR HIFU 49 DETERx ™ 49 I# I# [002] 49 interferon inducible 49 TLR9 agonist IMO 49 4.deb Size/MD5 49 Posaconazole 49 API JSR 49 memantine Namenda 49 tyrosine kinase inhibitor TKI 49 Bioral Amphotericin B. 49 developing Zerenex ferric 49 NB S# strontium malonate 49 investigational integrase inhibitor 49 ibudilast 49 AEG# 49 acetylgalactosamine 6 49 DGAT 49 timolol maleate 49 Develops Novel 49 Captisol Enabled 49 QUALCOMM MSM# 49 Zemiva TM 49 lintuzumab SGN 49 NIH Publication 49 bevacizumab Avastin ® 49 triphendiol 49 demethylating agents 49 Hydrochlorothiazide Tablets 49 controlled multicenter Phase 49 Antigens 49 Alexza Staccato 49 Demonstrates Sustained 49 ocular formulation 49 R#/MEM 49 IMiDs ® 49 investigational protease inhibitor 49 Conjugates 49 positive allosteric modulator 49 MTP inhibitor 49 Anticalins R 49 ® Atom Processor 49 HER1 49 Microarray Scanner 49 MoxDuo ® 49 Onalta ™ 49 CYP#A# isoenzyme 49 therapeutic peptide 49 Viral Immunotherapy platform 49 SYCREST 49 DOR# 49 Altera Ships 49 Fully Buffered 49 compound ITMN 49 PSN# [001] 49 CardioVascular BioTherapeutics 49 MT#/MEDI-# 49 outlicensed 49 PTK# 49 Enzastaurin 49 Bevirimat 49 Renin Inhibitor 49 Assay Kits 49 NS4A 49 SiTel 49 TRANSDUR ™ 49 Histone Deacetylase 49 Angiotensin Converting Enzyme 49 receptor modulators 49 myelofibrosis polycythemia vera 49 intravenous recombinant 49 Prevalence Worldwide 49 include PLX IBD 49 Anti Tumor 49 IV acetaminophen 49 TI DRP 49 AFREZZA ® 49 liposome encapsulated 49 suppl. 49 selective S#P# receptor agonist